21 Cfr 809 (2024)

1. 21 CFR Part 809 -- In Vitro Diagnostic Products for Human Use - eCFR

  • No information is available for this page. · Learn why

  • (a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that “a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper.”

2. CFR - Code of Federal Regulations Title 21 - FDA

  • § 809.20 - General requirements for manufacturers and producers of in vitro diagnostic products. § 809.30 - Restrictions on the sale, distribution and use of ...

  • -

3. In vitro diagnostic - CFR - Code of Federal Regulations Title 21 - FDA

  • [CITE: 21CFR809]. TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES SUBCHAPTER H - MEDICAL DEVICES. PART ...

  • (a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise specified in a standard for a particular product class or as provided in paragraph (e) of this section. Section 201(k) of the act provides that "a requirement made by or under authority of this act that any word, statement, or other information appear on the label shall not be considered to be complied with unless such word, statement, or other information also appears on the outside container or wrapper, if any there be, of the retail package of such article, or is easily legible through the outside container or wrapper."

4. 21 CFR Part 809 | US Law | LII / Legal Information Institute

21 CFR Part 809 | US Law | LII / Legal Information Institute

5. 21 CFR § 809.10 - Labeling for in vitro diagnostic products.

  • (a) The label for an in vitro diagnostic product shall state the following information, except where such information is not applicable, or as otherwise ...

  • § 809.10 Labeling for in vitro diagnostic products.

21 CFR § 809.10 - Labeling for in vitro diagnostic products.

6. 21 CFR 809 - In-Vitro Diagnostic Products - GMP Publications

  • GMP Publications, Part 809 - In-Vitro Diagnostic Products.

  • GMP Publications, Part 809 - In-Vitro Diagnostic Products

7. [PDF] Food and Drug Administration 21 CFR Part 809 [Docket No. FDA-2023-N ...

8. [PDF] Draft Guidance for Industry and FDA Staff In Vitro Diagnostic (IVD ...

  • Oct 25, 2007 · 21 CFR Part 809, In Vitro Diagnostic Products for Human Use, found at http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm ...

9. [PDF] 2024-08934.pdf - Federal Register

  • Apr 29, 2024 · 21 CFR Part 809. [Docket No. FDA-2024-D-0083]. Enforcement Policy for Certain In Vitro Diagnostic Devices for Immediate Public Health. Response ...

10. Fair Debt Collection Practices Act | Federal Trade Commission

  • §809. Validation of debts §810. Multiple debts §811. Legal actions by debt collectors §812. Furnishing certain deceptive forms §813. Civil liability §814 ...

  • Fair Debt Collection Practices Act As amended by Public Law 111-203, title X, 124 Stat.

Fair Debt Collection Practices Act | Federal Trade Commission

11. FDA Regulation of Clinical Microbiology Diagnostic Devices

  • The Code of Federal Regulations (21 CFR 809.3) ... Part 809. In vitro diagnostic products for human ... Title 21. Food and Drugs. Chapter I. Food and Drug ...

  • As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice

FDA Regulation of Clinical Microbiology Diagnostic Devices

12. View Rule - RegInfo.gov

  • CFR Citation: 21 CFR 809. Legal Authority: 21 U.S.C. 321 21 U.S.C. 331 21 U.S.C. 351 21 U.S.C. 352 21 U.S.C. 360c ... Legal Deadline: None. Timetable: Action ...

  • This proposed rule would propose to amend the Food and Drug Administration’s regulations to make explicit that laboratory developed tests (LDTs) are devices under the Federal Food, Drug, and Cosmetic Act.

13. FDA's Final Rule on Laboratory-Developed Tests

  • May 8, 2024 · ... 21 C.F.R. Part 809, which governs IVDs. In addition to adding ... at 37444-45 (amending 21 C.F.R. § 809.3(a)). [4] As amended, the ...

  • The U.S. Food and Drug Administration's highly anticipated final rule on laboratory-developed tests was officially published in the Federal Register on Monday, May 6, 2024.

FDA's Final Rule on Laboratory-Developed Tests

14. Geographic Distribution of Suspected Alpha-gal Syndrome Cases - CDC

  • Jul 28, 2023 · 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. Sect. 241(d); 5 ... MMWR Morb Mortal Wkly Rep 2023;72:809–14. https://www.cdc.gov/mmwr ...

  • This report describes the number of suspected Alpha ...

Geographic Distribution of Suspected Alpha-gal Syndrome Cases - CDC
21 Cfr 809 (2024)

References

Top Articles
Latest Posts
Article information

Author: Delena Feil

Last Updated:

Views: 6505

Rating: 4.4 / 5 (45 voted)

Reviews: 92% of readers found this page helpful

Author information

Name: Delena Feil

Birthday: 1998-08-29

Address: 747 Lubowitz Run, Sidmouth, HI 90646-5543

Phone: +99513241752844

Job: Design Supervisor

Hobby: Digital arts, Lacemaking, Air sports, Running, Scouting, Shooting, Puzzles

Introduction: My name is Delena Feil, I am a clean, splendid, calm, fancy, jolly, bright, faithful person who loves writing and wants to share my knowledge and understanding with you.